22960-16-3, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22960-16-3, name is Isoquinoline-4-carbaldehyde, introducing its new discovery.
Isoquinoline aldehydes
Isoquinoline-4-aldehydes of the formula STR1 in which X denotes bromine or chlorine, R1 is phenyl optionally mono- or disubstituted by halogen, hydroxy, nitro, amino, or amino substituted by one or two aliphatic, cycloaliphatic or aromatic hydrocarbon radicals having from 2 to 18 carbon atoms, the nitrogen atom possibly being included in a heterocyclic ring, acyl amino, alkyl or alkoxy each having from 1 to 6 carbon atoms, benzoyloxy, or trifluoromethyl, or is pyridyl or thienyl; R2 is hydrogen, halogen, hydroxy, alkyl or alkoxy having from 1 to 6 carbon atoms, nitro, amino, benzyloxy, methylene dioxy or ethylene dioxy and m is 1 or 2; which are effective in the treatment of spasms and as tranquilizers.
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.22960-16-3, you can also check out more blogs about22960-16-3
Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem